Cost Utility Analysis in Recurrent Ovarian Cancer
The goal of this research study is to learn about the quality of life and sexual functioning of women with platinum-resistant ovarian cancer as they receive other treatments for the disease.
Researchers will study the costs for chemotherapy treatments, other medical expenses, and treatment-related expenses that are not medical. Researchers will also review any symptoms these patients may experience related to the cancer or treatment.
In addition, researchers want to learn if and how these patients' caregivers feel the status of these patients' health may have affected the caregivers' productivity at work and at home.
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Quality of Life and Cost Utility Analysis in the Treatment of Recurrent, Platinum-Resistant Ovarian Cancer|
- Mean Score for the FACT-O instrument [ Time Frame: First 2 days of chemotherapy cycles ] [ Designated as safety issue: No ]Participants will complete questionnaires 1 - 5 at baseline and Day 1 of each of their chemotherapy cycles.
|Study Start Date:||December 2008|
|Study Completion Date:||January 2011|
|Primary Completion Date:||January 2011 (Final data collection date for primary outcome measure)|
Longitudinal measure of QOL, sexual functioning and symptoms in women with recurrent, platinum-resistant ovarian cancer receiving multiple second-line treatment regimens
Questionnaires 1 - 5 will be completed on Day 1 of study as a Baseline.
Other Name: Survey
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT00813254
|United States, Texas|
|UT MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Michael M Frumovitz, MD||M.D. Anderson Cancer Center|